PHARVARIS N V's ticker is PHVS and the CUSIP is N69605108. A total of 22 filers reported holding PHARVARIS N V in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $450,687 | +53.9% | 21,595 | +15.8% | 0.00% | – |
| Q2 2023 | $292,881 | +100.9% | 18,643 | 0.0% | 0.00% | – |
| Q1 2023 | $145,788 | +69655.0% | 18,643 | 0.0% | 0.00% | – |
| Q4 2022 | $209 | -99.9% | 18,643 | 0.0% | 0.00% | – |
| Q3 2022 | $149,000 | -63.8% | 18,643 | 0.0% | 0.00% | – |
| Q2 2022 | $412,000 | +18.4% | 18,643 | 0.0% | 0.00% | – |
| Q1 2022 | $348,000 | +18.4% | 18,643 | 0.0% | 0.00% | – |
| Q4 2021 | $294,000 | -8.4% | 18,643 | 0.0% | 0.00% | – |
| Q3 2021 | $321,000 | -5.0% | 18,643 | 0.0% | 0.00% | – |
| Q2 2021 | $338,000 | -26.4% | 18,643 | +13.8% | 0.00% | – |
| Q1 2021 | $459,000 | – | 16,384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,261,926 | $60,770,000 | 8.21% |
| venBio Partners LLC | 2,303,310 | $42,911,000 | 5.06% |
| Bain Capital Life Sciences Investors, LLC | 3,180,601 | $59,255,000 | 3.88% |
| Foresite Capital Management V, LLC | 364,142 | $6,784,000 | 2.67% |
| VR Adviser, LLC | 902,882 | $16,821,000 | 2.04% |
| Cormorant Asset Management, LP | 744,863 | $13,634,000 | 0.46% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,032,757 | $19,240,000 | 0.34% |
| GENERAL ATLANTIC, L.P. | 2,420,155 | $45,087,000 | 0.32% |
| Opaleye Management Inc. | 79,837 | $1,487,000 | 0.25% |
| Avidity Partners Management LP | 400,000 | $7,452,000 | 0.20% |